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Abstract 
Background: Growing evidence suggests that critical illness often results in significant long‑term neurocognitive 
impairments in one‑third of survivors. Although these neurocognitive impairments are long‑lasting and devastating 
for survivors, rehabilitation rarely occurs during or after critical illness. Our aim is to describe an early neurocognitive 
stimulation intervention based on virtual reality for patients who are critically ill and to present the results of a proof‑
of‑concept study testing the feasibility, safety, and suitability of this intervention.
Methods: Twenty critically ill adult patients undergoing or having undergone mechanical ventilation for ≥24 h 
received daily 20‑min neurocognitive stimulation sessions when awake and alert during their ICU stay. The difficulty 
of the exercises included in the sessions progressively increased over successive sessions. Physiological data were 
recorded before, during, and after each session. Safety was assessed through heart rate, peripheral oxygen saturation, 
and respiratory rate. Heart rate variability analysis, an indirect measure of autonomic activity sensitive to cognitive 
demands, was used to assess the efficacy of the exercises in stimulating attention and working memory.
Results: Patients successfully completed the sessions on most days. No sessions were stopped early for safety 
concerns, and no adverse events occurred. Heart rate variability analysis showed that the exercises stimulated atten‑
tion and working memory. Critically ill patients considered the sessions enjoyable and relaxing without being overly 
fatiguing.
Conclusions: The results in this proof‑of‑concept study suggest that a virtual‑reality‑based neurocognitive interven‑
tion is feasible, safe, and tolerable, stimulating cognitive functions and satisfying critically ill patients. Future studies 
will evaluate the impact of interventions on neurocognitive outcomes.
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Background
Growing evidence suggests that critical illness often 
results in significant long-term morbidities. One-
third of patients in intensive care units (ICU) develop 
neurocognitive impairments in a magnitude similar to 
mild–moderate dementia [1] persisting for years after 
hospital discharge [2, 3]. ICU-related neurocognitive 
impairments are particularly pronounced in regard to 
memory, executive functions, attentional functions, 
and processing speed [1, 3–10]. These impairments 
have far-reaching consequences and adversely impact 
patients’ lives, contributing to impaired ability to perform 
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activities of daily living, to decreased quality of life for 
patients and relatives, to increased medical costs, and 
to inability to return to work [11, 12]; however, patients 
rarely undergo rehabilitation during or after critical 
illness.
Rehabilitation strategies during the ICU stay have 
mainly involved physical interventions such as early 
mobilizations [13–16] to enhance functional recovery. 
Other strategies include early detection and treatment 
of delirium [17], and occupational therapy [18]. Recently, 
early rehabilitation strategies in the ICU have been 
extended beyond physical therapy to include cognitive 
interventions [19].
Physical and cognitive rehabilitation tools based on 
new technologies are being used successfully in patients 
with dementia, traumatic brain injury, stroke [20], and 
schizophrenia [21]. However, critically ill patients are 
usually bedridden and often unable to communicate ver-
bally, posing special challenges for the development and 
use of technologies for cognitive intervention. Thus, we 
sought to design a virtual-reality-based intervention that 
could be used to provide critically ill patients with neuro-
cognitive stimulation early in the ICU stay.
Another challenge in this context is determining 
whether an intervention actually results in brain stimula-
tion. Heart rate variability (HRV), a surrogate marker of 
sympathetic and vagal activity, is a particularly sensitive 
index of the changes in the neural network in response 
to cognitive requirements. The magnitude of the changes 
in HRV is inversely related to the individual level of cog-
nitive effort during cognitive tasks. HRV decreases dur-
ing tasks involving specifically selective and maintained 
attention [22, 23] and executive functions [24, 25]. Thus, 
HRV analysis seems useful to confirm that neurocogni-
tive intervention results in brain stimulation in critically 
ill patients.
This paper describes a virtual-reality-based early neu-
rocognitive stimulation intervention in critically ill 
patients and presents preliminary results of a proof-of-
concept study to assess the feasibility and safety of the 
intervention, its tolerability in terms of difficulty and 
cognitive load, and the effectiveness of the cognitive exer-
cises in stimulating the brain. Some of these results have 
been presented in abstract form [26–28].
Methods
Inpatient early neurocognitive intervention
An interdisciplinary team of neuropsychologists, 
nurses, critical care physicians, and biomedical engi-
neers designed the Early Neurocognitive Rehabilitation 
in Intensive Care (ENRIC) platform for neurocognitive 
stimulation in critically ill patients. This platform uses 
stimulation software with low cognitive load exercises 
specifically designed or adapted for critically ill patients. 
The stimulation software is based on virtual reality tech-
niques immersing patients in a relaxing environment; a 
virtual avatar accompanies patients, orienting them in 
time, delivering instructions, motivating them to com-
plete exercises, and encouraging them to relax. Different 
exercises based on exercises proven effective in cognitive 
rehabilitation programs for acquired brain injury focus 
on attention and executive functions [20]. Details about 
the stimulation software and videos are reported in the 
Additional files 1 and 2. The ENRIC platform consists of 
a central processing unit, a flat-screen TV, and a motion 
sensor  (Kinect® Microsoft, Redmond, Washington, USA) 
placed on a medical cart to allow it to be moved easily to 
each ICU bed. The system captures and interprets patient 
movements through smart middleware connecting 
the cognitive stimulation software with input from the 
motion sensor. This approach to patient–system interac-
tion avoids the risk of cross-infections inherent in sharing 
physical devices such as joysticks and touch tablets. The 
platform also incorporates a system to collect and store 
physiological data  (BetterCare®, Barcelona, Spain) from 
bedside monitors and ventilators [29] that could be used 
to adapt the level of cognitive stimulation to patients’ 
clinical condition (Fig. 1). The ENRIC platform turns on 
when it is plugged in. Before each session, it is necessary 
to calibrate the  Kinect® motion sensor and to adjust the 
distance between the patient and sensor; patients are 
asked to raise their hands in front of the sensor to check 
detection and motion recognition. Sometimes, the ICU 
bed needs to be raised or lowered. Bed adjustments and 
sensor calibration take less than 2 min. Although patients 
have no physical contact with any components of the 
device at any time, for reasons of infection control, the 
device is cleaned and disinfected after each session when 
it is used in isolated patients.
Patients
Patients were recruited from a mixed medical/surgical 
ICU with 16 beds in single rooms at a university teach-
ing hospital. Patients aged 18–85  years old who were 
undergoing or had undergone invasive mechanical ven-
tilation for ≥24 h were eligible. Patients with a history of 
neurologic disease, dementia, focal brain injury at ICU 
admission, serious psychiatric disorders, or mental retar-
dation were excluded. Deaf and/or blind patients were 
also excluded. Eligible patients were screened daily and 
invited to participate when they achieved minimum lev-
els of consciousness to interact with the ENRIC platform 
[Glasgow Coma Scale (GCS) ≥13] and sedation (Rich-
mond Agitation–Sedation Scale (RASS) −1 to +1).
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Procedure
Demographic data and severity (Acute Physiologic 
and Chronic Health Evaluation II (APACHE-II) and 
Sequential Organ Failure Assessment (SOFA) scores) 
were recorded at inclusion. Level of consciousness was 
assessed daily from ICU admission to initiation of the 
intervention. Upon reaching GCS ≥13, patients were 
screened daily for delirium using the Spanish version of 
the Confusional Assessment Method for the Intensive 
Care Unit (CAM-ICU) and for level of alertness using the 
RASS.
 Patients received the neurocognitive stimulation ses-
sions each day in their own beds when they were alert 
and calm (RASS −1 to +1) until discharge from the 
ICU. Sessions were guided by a neuropsychologist and 
supervised by an ICU nurse. Sessions aimed to provide 
cognitive stimulation and engagement through exercises, 
not necessarily obtaining correct answers. The exercises 
included in each session were determined by patients’ 
alertness level and ability to raise each arm separately 
with elbow straight against gravity (see Additional file 3: 
Figure S1 for a detailed description of the protocol). 
The clinical team predefined the length of the session 
as a minimum of 15 and maximum of 20 min. However, 
whenever clinical conditions allowed it, patients were 
encouraged to continue as long as they could without 
fatigue. Physiological data were recorded 20  min before 
sessions, during sessions, and after sessions.
Before this proof-of-concept study, six healthy volun-
teers tested the ENRIC platform in a session simulating 
ICU patients’ situation and then rated their experience 
on a five-point Likert scale. The first six patients included 
in the study also completed the same ad hoc survey about 
their experience with the ENRIC platform. Finally, ICU 
personnel, including nurses, physicians, and physiothera-
pists, were asked to complete an acceptance survey, giv-
ing their opinions about the compatibility of the ENRIC 
platform with ICU workload (see Additional file 4).
Measures
Feasibility was assessed in terms of the practicability of 
delivering neurocognitive stimulation early during criti-
cal illness: rates of patients eligible to receive the inter-
vention and of patients who underwent the intervention, 
number of sessions performed, timing of initiation, and 
duration of each session.
Safety was assessed by considering the sessions that 
had to be stopped early for clinical reasons, through 
analyses of heart rate (HR), peripheral oxygen satura-
tion  (SpO2), and respiratory rate (RR). The safety analy-
sis was based on expert consensus criteria for unsafe 
active mobilization of mechanically ventilated critically 
ill patients [30]:  SpO2 < 90%, RR > 35 breaths per minute, 
and HR > 150 beats per minute, all during ≥5 min. When 
out-of-range values were present at the beginning of the 
session, changes >20% from baseline in any physiological 
parameter were also considered unsafe events requiring 
the session to be stopped.
Tolerability was assessed in terms of the extent to 
which sessions were completed and to which patients 
tolerated the difficulty and cognitive load of the exer-
cises included. Thus, we recorded number of interrupted 
sessions and cause of interruption, as well as the type of 
exercises in each session.
The effectiveness in stimulating the brain was assessed 
in terms of autonomic reactivity during sessions using 
Fig. 1 Schematic diagram of the smart middleware connecting ENRIC platform, bedside monitor and ventilator (screenshots of bedside monitor 
and ventilator courtesy of  BetterCare®, Barcelona, Spain). The platform uses smart middleware to connect the cognitive stimulation software with 
input from a motion sensor  (Kinect®, Microsoft, Redmond, Washington, USA) that captures and interprets patient movements. The platform also 
incorporates a system to collect and store physiological data  (BetterCare®, Barcelona, Spain) from bedside monitors and ventilators that could be 
used to adapt the level of cognitive stimulation to patients’ clinical condition
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HRV frequency-domain analyses [31]. Spectral analy-
sis was performed over consecutive 2-min R–R inter-
vals series with an overlap of 1 min to ensure an analysis 
interval as stationary as possible. HRV was derived from 
the detected normal beat occurrence time series using 
the integral pulse frequency modulation (IPFM) model, 
which takes ectopic beats into accounts [32]. Since the 
mean heart rate is not constant (it evolves continuously 
in challenging situations, such as physical and mental 
effort, especially in critically ill patients), the HRV sig-
nal was corrected by the time-varying mean heart rate 
[33], yielding the modulating signal which, according to 
the IPFM model, represents autonomic nervous system 
modulation over the sinoatrial node. The modulating 
signal was sampled at 4 Hz, and its power spectral den-
sity was estimated. Low-frequency (LF) power and high-
frequency (HF) power were computed by integrating the 
area under the power spectral density in the LF and HF 
bands, respectively. The LF band was 0.04–0.15 Hz. The 
HF band was centered on the respiratory frequency, and 
bandwidth ranged from 0.15 to 0.3 Hz in function of res-
piratory stability. We also included total power, an index 
of overall autonomic modulation summing the power in 
the LF and HF bands. LF values were normalized (LFn) 
by total power to exclusively reflect sympathetic modula-
tion [31] and were expressed in normalized units, while 
HF values were expressed in adimensional units to reflect 
parasympathetic activity.
Statistical analysis
Mean scores on the satisfaction survey were computed 
from the individual raw scores for all items included 
in each category after converting scores of negatively 
worded items to positives. Mean scores were analyzed 
using the Mann–Whitney U test.
No formal power calculations were undertaken; rather 
sufficient participants were recruited during ~9  months 
to determine factors such as recruitment rates in relation 
to feasibility outcomes.
Feasibility, safety, and tolerability outcomes were ana-
lyzed using descriptive statistics. To analyze whether the 
intervention actually stimulated the brain, LFn, HF, and 
total power indices during the sessions were compared 
with baseline values using the Wilcoxon signed-rank 
test, because values for these variables were not normally 
distributed. Because patients received the total range of 
neurocognitive exercises during the first three sessions, 
to avoid potential effects on autonomic reactivity due to 
the lack of novelty in subsequent sessions, HRV analysis 
was limited to the first three sessions.
All analyses were performed with SPSS version 19.0 
(IBM, Armonk, NY); significance was set at 0.05. Results 
are presented as means and ranges or n/N (%), unless 
otherwise noted.
Results
Patients’ clinical and sociodemographic characteristics
Between April 2014 and December 2014, 193 patients 
were admitted to the ICU; 148 met at least one exclusion 
criterion. Of the 45 eligible patients, 25 were excluded 
for the following reasons: 12 were discharged within 
48  h, 7 remained unconscious, 4 were transferred to 
other centers, and 2 did not consent (Fig.  2). Thus, 20 
patients received the early neurocognitive intervention; 
Table 1 summarizes their clinical and sociodemographic 
characteristics.
Feasibility of early neurocognitive stimulation
All 20 patients (100%) received the early neurocognitive 
intervention on at least one study day. The first session 
was delivered 10.0 (2.0–23.0) days after ICU admission. 
Once patients started the intervention, sessions were 
delivered on 74.3% (25.0–100.0%) of the eligible study 
days until ICU discharge.
During the study, 76 sessions were delivered [mean 
number of sessions per patient, 3.8 (1.0–8.0); mean dura-
tion of each session, 17.5 (12.0–31.0) minutes].
Safety of early neurocognitive stimulation
Table  2a, b summarizes HR, RR, and  SpO2 at baseline, 
during the session, and after the session and indicates the 
percentage of patients who were mechanically ventilated 
during each session. No unsafe HR values were observed 
in recordings at baseline or during the session; after the 
first session, unsafe HR values lasting less than 5  min 
were observed in one patient (1/20, 5%) after the first ses-
sion and in another patient (1/11, 9.1%) after the fourth. 
During sessions, some patients reached unsafe minimum 
 SpO2 values lasting less than 5 min (session #1: 2/20, 10%; 
session #2: 1/17, 5.9%; session #3: 1/13, 7.7%; and session 
#4: 1/11, 9.1%), and some patients reached unsafe RR 
(session #1: 6/20, 30%; session #2: 11.8%; session #3: 2/13, 
15.4%; session #4: 3/11, 27.3%; session #5: 4/8, 50%; ses-
sion #6: 1/4, 25%; and session #7: 1/2, 50%). Nevertheless, 
no sessions were stopped early for safety concerns, and 
no adverse events (e.g., inadvertent removal of catheters 
or endotracheal tubes) occurred. No changes in physi-
ological parameters ≥20% from baseline were observed 
during the sessions. No patients received vasoactive 
agents during sessions.
Tolerability of early neurocognitive stimulation
Patients completed 66/76 (86.8%) of possible neurocogni-
tive stimulation sessions. Most (70%) incomplete sessions 
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occurred on the first day. Reasons for discontinuing a ses-
sion were fatigue (50%), extreme sleepiness (20%), com-
peting medical procedures (20%), and confusion (10%). 
Discontinuation did not preclude participation in subse-
quent sessions.
Figure 3 illustrates the composition of the first five ses-
sions, with progressively more challenging exercises. In 
the first session, passive exercises requiring simple atten-
tion and gross motor functions accounted for 55.6% of 
the total time. In subsequent sessions, the time spent 
on passive exercises gradually decreased, while the time 
spent on exercises requiring more complex cognitive 
effort (selective attention and working memory exercises) 
increased. Patients correctly followed the neuropsycholo-
gist’s orders in the guided-observation exercises, which 
represented 34.2% of the total session time. Selective 
attention exercises accounted for 10.2% of the total time. 
The most complex exercises, focusing on working mem-
ory, were only performed from the third session, and the 
time assigned for these exercises was increased progres-
sively with each session. In the fifth session, equal time 
was assigned to each type of exercises.
Effectiveness of neurocognitive exercises in stimulating 
the brain
Table 3 displays the results of HRV analysis for the three 
main frequency-domain indices. In session #1, LFn was 
lower (p =  0.02) than baseline values. In session #2, all 
indices were lower than baseline (LFn, p  =  0.01; HF, 
p = 0.03; and total power, p = 0.01). In session #3, total 
power was lower than baseline (p = 0.02).
Satisfaction and acceptance survey results
Table S1 compares satisfaction survey scores between 
healthy volunteers and critically ill patients (see Addi-
tional file  4). Patients scored higher than volunteers for 
relaxation (p = 0.002) and system interaction (p = 0.004) 
and lower for boredom (p  =  0.041). Additional file  4: 
Table S2 reports the scores on the acceptance survey 
for ICU personnel, including the overall mean as well as 
mean scores for physicians, nurses, and physiotherapists. 
The lowest rated item was Compatibility with physical 
infrastructure and ICU facilities, and the highest rated 
items were Compatibility with pharmacologic treatment 
and Compatibility with physiotherapy.
193 admitted to the ICU
148 excluded
88 non-mechanically ventilated or mechanically ventilated <24h 
33 previous neurologic pathology or brain injury at admission
16 died
3 aged >85 years old
2 sensory impaired or unable to speak Spanish
2 aged <18 years old
2 with severe psychiatric pathology
1 preventive isolation
1 limitation of therapeutic effort
45 eligible 
25 excluded
12 discharged within 48 hours
7 unconscious (GCS <8)
4 transferred to another hospital
2 no consent
20  included
Fig. 2 Flow diagram of sample. During a period comprising ~9 months, 193 patients were admitted to the ICU; 148 met at least one exclusion 
criterion. Of the 45 eligible patients, 25 were finally excluded. Thus, 20 patients received the early neurocognitive intervention
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Discussion
Our results indicate that this virtual-reality-based neu-
rocognitive intervention is feasible, safe, and tolerable 
for critically ill patients (including mechanically venti-
lated patients) and that the exercises used provide cogni-
tive stimulation. The satisfaction and acceptance surveys 
found that critically ill patients considered the sessions 
enjoyable and relaxing without being overly fatiguing. 
Furthermore, ICU personnel considered the neurocogni-
tive intervention compatible with the routine workload 
and the usual treatments prescribed in the ICU.
Neurocognitive impairments in ICU survivors may 
be understood as a manifestation of occult brain dam-
age resulting from pathophysiological mechanisms 
related to critical illness and crosstalk between organs 
[34, 35]. Therefore, it might be interesting to consider 
ICU patients as a subset of brain-injured patients and 
treat them with tools such as cognitive stimulation that 
have proven effective in treating neurocognitive impair-
ments in outpatient populations [36]. However, neu-
rocognitive stimulation techniques commonly used in 
post-acute patients are often unfeasible in critically ill 
patients, who may be bedridden, have low awareness lev-
els that fluctuate during the day, have reduced mobility 
due to myopathy and ICU-acquired weakness, and are 
unable to communicate verbally because they are receiv-
ing mechanical ventilation. To overcome these barri-
ers to implementing neurocognitive interventions in the 
ICU, clinicians need safe, feasible, and easy-to-use tools 
for neurocognitive stimulation. To our knowledge, this 
study is the first to establish a proof of concept for vir-
tual-reality-based neurocognitive stimulation in critically 
ill patients.
The motion sensor in the ENRIC platform provides a 
feasible solution to mobility and communication prob-
lems in early neurocognitive stimulation for critically 
ill patients. Brummel et  al. [19] started an intervention 
combining physical therapy and cognitive therapy within 
72 h after ICU admission when patients achieved RASS 
−3 to −2, but their cognitive protocol started only when 
they achieved RASS −1 to +1. In our study, neurocog-
nitive stimulation started when patients reached RASS 
−1 to +1 (median, 10  days after ICU admission; range 
2–23  days), suggesting that deep-sedation strategies, 
in addition to leading to increased prevalence of brain 
dysfunction in ICU [37], are the most important barrier 
to this kind of interventions in the ICU. In a pilot study 
of feasibility of physical interventions in critically ill 
patients, profound levels of sedation made 27% of physi-
cal sessions impossible [38]; protocols reducing seda-
tion could help enable both physical and neurocognitive 
interventions in the ICU. Nonetheless, patients in our 
study successfully received neurocognitive stimulation 
during 74.3% of their time in the ICU, reflecting a wide 
therapeutic window for treatment.
No sessions were stopped early for safety concerns, and 
no adverse events (e.g., inadvertent removal of catheters 
or endotracheal tubes) occurred. Patients’ tolerance to 
increasingly difficult exercises in neurocognitive stimula-
tion sessions increased as patients’ physical and cognitive 
status improved, showing that the intervention is safely 
adaptable to each patient’s physical and cognitive condi-
tion from the first day to ICU discharge.
Importantly, the intervention seems effective in stim-
ulating the brain. Our HRV analysis found an over-
all decrease in the spectral components of HRV during 
the neurocognitive stimulation intervention. Since 
HRV decreases when attentional [22, 23] and executive 
Table 1 Clinical and  sociodemographic characteristics 
of  critically ill patients undergoing early neurocognitive 
intervention (n = 20)
APACHE-II Acute Physiology and Chronic Health Evaluation II, ARDS acute 
respiratory distress syndrome, GCS Glasgow Coma Scale, ICU intensive care unit, 
IQR interquartile range, LoS length of stay, M mean, Md median, MV mechanical 
ventilation, SD standard deviation
Age, years (M, SD) 65 10
Sex (N,  %)
 Male 14 63.66
 Female 6 27.33
Diagnosis (N,  %)
 Medical
  Pneumonia 3 15
  Septic shock 3 15
  Acute respiratory failure 1 5
  ARDS 1 5
  Pancreatitis 1 5
  Toxic intake 1 5
 Unplanned surgery
  Peritonitis 3 15
  Multiple trauma 2 10
  Intestinal perforation 2 10
  Pneumoperitoneum 1 5
 Planned surgery
  Hemorrhagic shock 1 5
  Esophageal perforation 1 5
Receiving MV at inclusion (N,  %) 7 35
APACHE‑II (M, SD) 24.84 9.04
SOFA (M, SD) 9.58 4.23
GCS (M, SD) 10.33 5.91
ICU LoS, days (Md, IQR) 16.00 2.00
Total MV time, days (Md, IQR) 9.50 1.00
Sedation, days (Md, IQR) 5.00 0.00
Delirium, days (Md, IQR) 1.39 0.80
Septic shock (N,  %) 12 60
Cardiac arrest (N,  %) 1 5
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functions [24, 25] are stimulated, these results indicate 
that the intervention stimulated these cognitive functions 
in our critically ill patients, including those with low 
alertness levels.
There is some evidence that neurocognitive interven-
tions can help mitigate long-term ICU-related neurocog-
nitive deficits. Jackson et  al. [39] found that combined 
cognitive and physical therapy improved executive func-
tion and instrumental activities of daily living in a sample 
of ICU survivors. However, delaying interventions until 
after ICU discharge may be less effective, and introducing 
interventions only when cognitive and physical decline 
has already appeared seems insufficient to completely 
reverse deficits [40]. Early neurocognitive stimulation 
promises to improve outcomes in critically ill patients, 
potentially decreasing the incidence and duration of 
delirium, shortening ICU and hospital stays, and ulti-
mately reducing costs while improving cognitive function 
and quality of life after discharge. Nevertheless, neu-
rocognitive interventions are rarely routinely delivered 
during hospitalization. Our small sample from a single 
center limits the generalizability of our specific findings. 
However, this proof-of-concept study aimed only to 
assess feasibility of neurocognitive stimulation in the 
ICU. Therefore, many key questions were not addressed 
(e.g., the best type of intervention or exercises for cogni-
tive stimulation, the optimal time to start neurocogni-
tive interventions, the optimal duration and intensity of 
interventions, and impact of interventions on long-term 
outcomes). These questions should be assessed in larger 
samples. Ultimately, HRV can be influenced by certain 
drugs typically prescribed in ICU, among which include 
anticholinergic drugs, agents with effect on adrenergic 
receptors, angiotensin-converting enzyme inhibitors, or 
even calcium channel blockers, so the effect should be 
considered cautiously while interpreting HRV results.
Fig. 3 Time distribution (%) of neurocognitive exercises for each session during the first five sessions. In the first session, passive exercises requiring 
simple attention and gross motor functions were the most performed exercises. In subsequent sessions, the time spent on passive exercises gradu‑
ally decreased, while the time spent on exercises focusing on selective attention and working memory increased. Guided‑observation exercises were 
well tolerated for patients from the first session. The most complex exercises, focusing on working memory, were only performed from the third ses‑
sion, and the time assigned for these exercises was increased progressively with each session. Note that in the fifth session, equal time was assigned 
to each type of exercises
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Conclusions
This proof-of-concept study shows that virtual-reality-
based neurocognitive interventions are feasible, safe, and 
tolerable for critically ill patients. It also shows that the 
ENRIC platform stimulates cognitive functions and was 
well received by patients. These preliminary results lay 
the groundwork for implementing such interventions on 
a larger scale to evaluate their efficacy.
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